Lupus (SLE): vizsgálatok itt: Görögország
14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Chaïdári
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Where
- Chaïdári, Efkarpia, Thessaloniki
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07332481 · EU 2025-523871-44-00 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Where
- Athens, Heraklion
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07355218 · EU 2025-524855-30-00 - 3. fázisTaking peopleA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Where
- Athens, Chaïdári, Heraklion, Larissa
- Életkor
- 18 év to 75 év
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07438496 · EU 2025-523552-31-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Where
- Athens, Heraklion, Larissa
- Életkor
- 16 év and over
- People
- 450 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06617325 · EU 2023-508191-11-00 - 2. fázisTaking peopleObe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Where
- Athens, Patras
- Életkor
- 12 év to 65 év
- People
- 35 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT07053800 · EU 2024-519941-32-00 - 3. fázisNot yet taking people in GörögországRollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.
- Where
- Chaïdári
- People
- 340 worldwide
- Run by
- AstraZeneca AB
See details and how to join2026-526419-13-00 · EU 2026-526419-13-00 - 3. fázisCsak meghívásosA Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
- Where
- Athens, Heraklion, Larissa
- Életkor
- 16 év and over
- People
- 760 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT04976322 · EU 2023-506368-14-00 - 1. fázisNot yet taking people in GörögországA study to learn how dapirolizumab pegol transfers to babies from pregnant mothers with active systemic lupus erythematosus
- Where
- DO NOT EDIT
- Életkor
- Up to 64 év
- People
- 10 worldwide
- Run by
- UCB Biopharma
See details and how to join2025-524595-37-00 · EU 2025-524595-37-00 - 3. fázisCsak meghívásosA Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
- Where
- Athens
- Életkor
- 18 év and over
- People
- 864 worldwide
- Run by
- Biogen
See details and how to joinNCT05352919 · EU 2023-505635-13-00 - 3. fázisCsak meghívásosLong-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
- Where
- Athens, Chaïdári, Thessaloniki
- Életkor
- 18 év to 75 év
- People
- 680 worldwide
- Run by
- Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00 - 1. fázisTaking peopleA study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus
- Where
- Athens, Thessaloniki
- Életkor
- 18 év and over
- People
- 11 worldwide
- Run by
- Climb Bio Inc.
See details and how to join2024-520385-57-01 · EU 2024-520385-57-01 - 1. fázisTaking peopleA Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
- Where
- Exochi, Thessaloniki
- Életkor
- 18 év to 65 év
- People
- 30 worldwide
- Run by
- Climb Bio, Inc.
See details and how to joinNCT07011043 - No phaseTaking peopleDoes Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study
- Where
- Athens
- Életkor
- 18 év and over
- People
- 684
- Run by
- Biomedical Research Foundation, Academy of Athens
See details and how to joinNCT07056621